Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,280
+$15,714 QoQ
Shares Held
848
+2074.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Services Network, LLC holds $28,927,722 across 25 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,566 | $5,845,518 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,289 | $2,674,357 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,141 | $2,553,682 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
230,454 | $2,263,058 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,356 | $1,913,344 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
17,371 | $1,415,907 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,135 | $1,409,315 | |
| 8 | EXEL |
Exelixis, Inc.
|
20,558 | $1,118,559 |
All Filings in DNLI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,280 | 848 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $566 | 39 | Shares | Sole | 2025-11-18 | |
| 2023-12-31 | $6,631 | 309 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $6,912 | 300 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $8,343 | 300 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $150,761 | 1,922 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $207,786 | 3,639 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $478,269 | 5,710 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $201,328 | 5,619 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $91,857 | 5,246 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||